Evan Seigerman
Stock Analyst at BMO Capital
(4.73)
# 702
Out of 5,005 analysts
1080
Total ratings
57%
Success rate
10.4%
Average return
Main Sectors:
Stocks Rated by Evan Seigerman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MRK Merck & Co. | Reiterated: Buy | $170 | $148.69 | +14.33% | 51 | Sep 25, 2026 | |
| VRTX Vertex Pharmaceuticals | Reiterated: Buy | $600 | $527.67 | +13.71% | 72 | Sep 23, 2026 | |
| NVO Novo Nordisk | Reiterated: Hold | $47 | $38.71 | +21.42% | 58 | Sep 21, 2026 | |
| AMGN Amgen | Reiterated: Hold | $450 | $418.13 | +7.62% | 72 | Sep 16, 2026 | |
| BNTX BioNTech SE | Reiterated: Hold | $105 | $99.08 | +5.97% | 18 | Sep 14, 2026 | |
| SRRK Scholar Rock Holding | Reiterated: Buy | $76 → $84 | $49.13 | +70.97% | 13 | Sep 14, 2026 | |
| IRON Disc Medicine | Reiterated: Buy | $100 | $64.92 | +54.04% | 31 | Sep 10, 2026 | |
| REPL Replimune Group | Reiterated: Buy | $20 | $12.56 | +59.24% | 35 | Sep 10, 2026 | |
| BIIB Biogen | Reiterated: Hold | n/a | $228.69 | - | 64 | Sep 9, 2026 | |
| BMY Bristol-Myers Squibb Company | Reiterated: Hold | $60 | $63.88 | -6.07% | 70 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $300 | $266.28 | +12.66% | 28 | Sep 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $130 | $124.82 | +4.15% | 55 | Aug 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1,400 | $1,184.78 | +18.17% | 121 | Aug 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $178 | $142.59 | +24.83% | 6 | Aug 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $174 | $152.21 | +14.32% | 81 | Aug 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 | $20.53 | +75.35% | 11 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $13.92 | +7.76% | 12 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $190 | $140.44 | +35.29% | 48 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $28.72 | +4.46% | 56 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $800 | $752.25 | +6.35% | 79 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $29.50 | -18.64% | 19 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $10.45 | +91.39% | 3 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $39.00 → $43.00 | $32.11 | +33.91% | 2 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $145 | $35.07 | +313.52% | 21 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $4.99 | +180.56% | 9 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.51 | - | 3 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $28.48 | - | 4 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.12 | n/a | 1 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €116.05 → €131.87 | €138.45 | n/a | 3 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $11.19 | n/a | 5 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $5.60 | n/a | 3 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $27 | $4.64 | n/a | 2 | Aug 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $9 → $15 | $13.37 | n/a | 6 | Dec 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €135.00 → €129.00 | €25.98 | n/a | 6 | Oct 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $0.69 → $0.84 | $1.19 | n/a | 6 | Aug 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $30 | $4.06 | n/a | 4 | May 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $169 → $220 | $29.84 | n/a | 2 | Feb 24, 2020 |
Merck & Co.
Sep 25, 2026
Reiterated: Buy
Price Target: $170
Current: $148.69
Upside: +14.33%
Vertex Pharmaceuticals
Sep 23, 2026
Reiterated: Buy
Price Target: $600
Current: $527.67
Upside: +13.71%
Novo Nordisk
Sep 21, 2026
Reiterated: Hold
Price Target: $47
Current: $38.71
Upside: +21.42%
Amgen
Sep 16, 2026
Reiterated: Hold
Price Target: $450
Current: $418.13
Upside: +7.62%
BioNTech SE
Sep 14, 2026
Reiterated: Hold
Price Target: $105
Current: $99.08
Upside: +5.97%
Scholar Rock Holding
Sep 14, 2026
Reiterated: Buy
Price Target: $76 → $84
Current: $49.13
Upside: +70.97%
Disc Medicine
Sep 10, 2026
Reiterated: Buy
Price Target: $100
Current: $64.92
Upside: +54.04%
Replimune Group
Sep 10, 2026
Reiterated: Buy
Price Target: $20
Current: $12.56
Upside: +59.24%
Biogen
Sep 9, 2026
Reiterated: Hold
Price Target: n/a
Current: $228.69
Upside: -
Bristol-Myers Squibb Company
Sep 9, 2026
Reiterated: Hold
Price Target: $60
Current: $63.88
Upside: -6.07%
Sep 3, 2026
Reiterated: Buy
Price Target: $300
Current: $266.28
Upside: +12.66%
Aug 31, 2026
Reiterated: Hold
Price Target: $130
Current: $124.82
Upside: +4.15%
Aug 31, 2026
Reiterated: Buy
Price Target: $1,400
Current: $1,184.78
Upside: +18.17%
Aug 30, 2026
Reiterated: Buy
Price Target: $178
Current: $142.59
Upside: +24.83%
Aug 27, 2026
Reiterated: Buy
Price Target: $174
Current: $152.21
Upside: +14.32%
Aug 18, 2026
Reiterated: Buy
Price Target: $36
Current: $20.53
Upside: +75.35%
Aug 17, 2026
Reiterated: Buy
Price Target: $15
Current: $13.92
Upside: +7.76%
Aug 17, 2026
Reiterated: Hold
Price Target: $190
Current: $140.44
Upside: +35.29%
Aug 17, 2026
Reiterated: Buy
Price Target: $30
Current: $28.72
Upside: +4.46%
Aug 17, 2026
Reiterated: Buy
Price Target: $800
Current: $752.25
Upside: +6.35%
Aug 17, 2026
Reiterated: Buy
Price Target: $24
Current: $29.50
Upside: -18.64%
Aug 13, 2026
Reiterated: Buy
Price Target: $20
Current: $10.45
Upside: +91.39%
Aug 12, 2026
Reiterated: Buy
Price Target: $39.00 → $43.00
Current: $32.11
Upside: +33.91%
Aug 6, 2026
Reiterated: Buy
Price Target: $145
Current: $35.07
Upside: +313.52%
Jun 30, 2026
Reiterated: Buy
Price Target: $14
Current: $4.99
Upside: +180.56%
Sep 30, 2025
Rated: Hold
Price Target: n/a
Current: $7.51
Upside: -
Sep 30, 2025
Rated: Hold
Price Target: n/a
Current: $28.48
Upside: -
May 6, 2025
Rated: Hold
Price Target: n/a
Current: $3.12
Upside: n/a
Oct 23, 2024
Reiterated: Buy
Price Target: €116.05 → €131.87
Current: €138.45
Upside: n/a
Aug 7, 2023
Rated: Hold
Price Target: n/a
Current: $11.19
Upside: n/a
May 9, 2023
Rated: Hold
Price Target: n/a
Current: $5.60
Upside: n/a
Aug 13, 2021
Reiterated: Buy
Price Target: $30 → $27
Current: $4.64
Upside: n/a
Dec 16, 2020
Upgraded: Buy
Price Target: $9 → $15
Current: $13.37
Upside: n/a
Oct 16, 2020
Reiterated: Hold
Price Target: €135.00 → €129.00
Current: €25.98
Upside: n/a
Aug 13, 2020
Reiterated: Sell
Price Target: $0.69 → $0.84
Current: $1.19
Upside: n/a
May 11, 2020
Reiterated: Buy
Price Target: $13 → $30
Current: $4.06
Upside: n/a
Feb 24, 2020
Reiterated: Hold
Price Target: $169 → $220
Current: $29.84
Upside: n/a